Long-Term COVID-19 Effects Are Caused by Brain Tissue Loss, New Research Finds
![Clinical laboratories and meta-analysis recently published casts doubts on serology test performance, Abbott antigen test](https://covid19briefings.com/wp-content/uploads/2020/07/AS_276691406-meta-analysis-of-serology-test-performance-sm.jpeg)
Brain imaging research would seem to indicate that the lasting effects of COVID-19 brain changes could be permanent.
CDC Releases Clinical Laboratory Test Recommendations for Long-Haul COVID-19 Symptoms
![concept of coinfections and covid](https://covid19briefings.com/wp-content/uploads/2020/09/AS-193234202-comorbidities-covid19-sm.jpeg)
A breakout of the CDC’s new focus on relatively routine clinical laboratory tests and four specialized lab tests based on a patient’s particular complaints.
CDC Releases New COVID-19 Testing Tool to Identify Patients Who Require COVID-19 Testing
![Questions about COVID testing](https://covid19briefings.com/wp-content/uploads/2020/08/AS_104477267-questions-about-test-results-sm-1024x709.jpg)
New online CDC tool intended to relieve confusion around when to test now, as well as enable healthcare providers to quickly identify patients who should be tested for COVID-19.
FDA Issues Second Class 1 Recall in Two Weeks for Unauthorized COVID-19 Test
![FDA maze of regulations](https://covid19briefings.com/wp-content/uploads/2020/05/AS_301344926-FDA-Blue-Maze-sm-1024x576.jpeg)
The FDA cited multiple reasons for issuing the warning and recall, including the fact that the test’s performance was not adequately established.
New Discovery Identifies How COVID-19 Overwhelms the Immune System, Potentially Providing New Targets for Testing and Treatments
![Clinical laboratories and meta-analysis recently published casts doubts on serology test performance, Abbott antigen test](https://covid19briefings.com/wp-content/uploads/2020/07/AS_276691406-meta-analysis-of-serology-test-performance-sm.jpeg)
What University of Southern California research showed about suppression of cells’ mitochondria in COVID-19 immune system response.
FDA Issues Public Safety Communication, Warning Public and Healthcare Providers About COVID-19 Tests Sold by Lepu Technology
![FDA maze of regulations](https://covid19briefings.com/wp-content/uploads/2020/05/AS_301344926-FDA-Blue-Maze-sm-1024x576.jpeg)
New FDA warnings for unauthorized COVID-19 tests demonstrates the FDA’s continued attention to unreliable COVID-19 testing.
FDA Updates SARS-CoV-2 Viral Mutation Page to Include Effects of New Variant on Mesa Biotech’s Accula SARS-CoV-2 Test
![FDA maze of regulations](https://covid19briefings.com/wp-content/uploads/2020/05/AS_301344926-FDA-Blue-Maze-sm-1024x576.jpeg)
SARS-CoV-2 variants continue to create new impacts on some COVID-19 tests, FDA warns.
Florida Laboratory to Begin Accepting Bitcoin as Payment for Point of Care COVID-19 Tests
![calculator concept covid19 testing calculator](https://covid19briefings.com/wp-content/uploads/2020/12/AS_280346896-sm-calculator-concept-covid19-test-calculator.jpg)
Bitcoin becomes a potential method of payment for COVID-19 testing for point-of-care tests performed by one Florida laboratory.
HHS Announces Allocation of $4.8 Billion for Funding COVID-19 Testing for the Uninsured
![Virus genome sequencing contact tracing information moving](https://covid19briefings.com/wp-content/uploads/2020/09/AS_309944527-C-concept-information-moving-1024x694.jpg)
New COVID-19 funding announced by HHS to reimburse healthcare providers for COVID-19 testing for the uninsured.
FDA Warns Against Using COVID-19 Antibody Testing to Evaluate for Immunity After COVID-19 Vaccination
![FDA maze of regulations](https://covid19briefings.com/wp-content/uploads/2020/05/AS_301344926-FDA-Blue-Maze-sm-1024x576.jpeg)
Despite considerable and growing interest in COVID-19 antibody testing for vaccinated individuals, the FDA’s new guidance seems to exclude such testing.